Table S8.

TP53 plasma mutations identified in 13 PDAC patients with TP53-mutant tumors

Sample ID	Plasma DNA concentration, ng/mL	Mutation identified in plasma	Mutant mean allele frequency, %	Mutant fragments/mL plasma
PANC 335	7.44	TP53 p.R196*, c.586C > T	0.795	18.2
PANC 336	7.66	TP53 p.G266E, c.797G > A	0.929	21.9
PANC 352	10.88	TP53 p.R175H, c.524G > A	0.673	22.6
PANC 387	6.22	TP53 p.R175H, c.524G > A	0.195	3.7
PANC 467	3.79	TP53 p.R248Q, c.743G > A	0.344	4.0
PANC 468	5.76	TP53 p.S241F, c.722C > T	0.139	2.5
PANC 469	3.35	TP53 p.C238F, c.713G > T	0.051	0.5
PANC 545	6.85	TP53 p.Y236C, c.707A > G	0.137	2.9
PANC 547	6.01	TP53 p.Y234C, c.701A > G	0.069	1.3
PANC 552	5.60	TP53 p.C238Y, c.713G > A	0.317	5.5
PANC 692	5.50	TP53 p.V272M, c.814G > A	0.101	1.7
PANCA 1105	6.43	TP53 p.H193Y, c.577C > T	0.098	1.9
PANCA 1109	15.44	TP53 p.Y234C, c.701A > G	0.351	16.7